Resona Asset Management Co.,Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Resona Asset Management Co.,Ltd.
- $16.6 Billion
- Q4 2024
A detailed history of Resona Asset Management Co.,Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 36,656 shares of ALNY stock, worth $9.75 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
36,656Holding current value
$9.75 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
674Shares Held
111MCall Options Held
1.23MPut Options Held
1.17M-
Capital World Investors Los Angeles, CA16.6MShares$4.42 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.39 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.54 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.85 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$1.12 Billion0.19% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...